Adimmune Corp Stock Net Asset
| 4142 Stock | TWD 27.60 0.05 0.18% |
Adimmune Corp fundamentals help investors to digest information that contributes to Adimmune Corp's financial success or failures. It also enables traders to predict the movement of Adimmune Stock. The fundamental analysis module provides a way to measure Adimmune Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adimmune Corp stock.
Adimmune |
Adimmune Corp Company Net Asset Analysis
Adimmune Corp's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Adimmune Corp Net Asset | 8.01 B |
Most of Adimmune Corp's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adimmune Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Adimmune Corp has a Net Asset of 8.01 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all Taiwan stocks is notably lower than that of the firm.
Adimmune Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adimmune Corp's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adimmune Corp could also be used in its relative valuation, which is a method of valuing Adimmune Corp by comparing valuation metrics of similar companies.Adimmune Corp is currently under evaluation in net asset category among its peers.
Adimmune Fundamentals
| Return On Equity | 0.0655 | |||
| Return On Asset | 0.0139 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 15.44 B | |||
| Shares Outstanding | 421.51 M | |||
| Shares Owned By Insiders | 16.90 % | |||
| Shares Owned By Institutions | 15.86 % | |||
| Price To Earning | (7.22) X | |||
| Price To Book | 2.47 X | |||
| Price To Sales | 6.17 X | |||
| Revenue | 1.64 B | |||
| Gross Profit | 464.14 M | |||
| EBITDA | 254.89 M | |||
| Net Income | 43.07 M | |||
| Cash And Equivalents | 654.9 M | |||
| Cash Per Share | 2.76 X | |||
| Total Debt | 1.27 B | |||
| Debt To Equity | 206.90 % | |||
| Current Ratio | 1.34 X | |||
| Book Value Per Share | 14.63 X | |||
| Cash Flow From Operations | (480.52 M) | |||
| Earnings Per Share | 1.20 X | |||
| Target Price | 35.0 | |||
| Number Of Employees | 36 | |||
| Beta | 0.54 | |||
| Market Capitalization | 17.01 B | |||
| Total Asset | 8.01 B | |||
| Retained Earnings | (253 M) | |||
| Working Capital | 1.02 B | |||
| Current Asset | 1.75 B | |||
| Current Liabilities | 732 M | |||
| Z Score | 7.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 8.01 B |
About Adimmune Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adimmune Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adimmune Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adimmune Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.